Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Files to Raise up to $100M in Potential Stock Offerings

NEW YORK (GenomeWeb News) – Third Wave Technologies said yesterday that it has field a shelf registration with the US Securities and Exchange Commission allowing it to sell up to $100 million in securities.
The molecular diagnostics company said it may sell an undetermined number of debt securities or common stock, which includes the rights to purchase preferred stock, and that all of these may be issued by exercising warrants.
Third Wave plans to use the proceeds of the sale of the securities, which have not been priced, for working capital, and for corporate purposes that could include R&D spending, capital expenses, and for acquisitions of companies, products, or technologies.
The Madison, Wis.-based company said it currently has no plans for any specific acquisitions, but that “opportunities may exist” for expansion through acquisition, alliances, or through other deals.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.